基于ASPECTS分区的烟雾病CT灌注与DSA侧支代偿的相关性研究

doi:10.3969/j.issn.1673-5765.2024.07.004

中国卒中杂志 ›› 2024, Vol. 19 ›› Issue (7): 755-761.DOI: 10.3969/j.issn.1673-5765.2024.07.004

基于ASPECTS分区的烟雾病CT灌注与DSA侧支代偿的相关性研究

杜海斌¹，孙剑¹，刘炜²，张东³

1 北京 102200 北京市昌平区医院神经外科
2 首都医科大学附属北京天坛医院神经外科
3 北京医院神经外科，国家老年医学中心，中国医学科学院老年医学研究院

收稿日期:2024-04-30 出版日期:2024-07-20 发布日期:2024-07-20
通讯作者: 张东 zhangdong0660@aliyun.com
基金资助:
国家重点研发计划项目（2021YFC2500502）

A Study on the Correlation between ASPECTS-Based CT Perfusion and DSA Collateral Compensation in Moyamoya Disease

DU Haibin¹, SUN Jian¹, LIU Wei², ZHANG Dong³

1 Department of Neurosurgery, Beijing Changping Hospital, Beijing 102200, China;
2 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China;
3 Department of Neurosurgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China

Received:2024-04-30 Online:2024-07-20 Published:2024-07-20
Contact: ZHANG Dong, E-mail: zhangdong0660@aliyun.com
Supported by:

摘要/Abstract

摘要：

目的探讨烟雾病患者CT灌注和DSA侧支代偿之间的相关性以及影响其大脑半球灌注的危险因素。

方法研究纳入115例成年烟雾病患者，共230个大脑半球，收集其DSA和CT灌注数据。ASPECTS分区用于划分大脑区域，对达峰时间（time to peak，TTP）、平均通过时间（mean transit time，MTT）、脑血流量（cerebral blood flow，CBF）和脑血容量（cerebral blood volume，CBV）这4项灌注血流动力学指标进行评分，并对DSA显示的脑血管侧支代偿进行评分。对4项CT灌注血流动力学指标和DSA侧支代偿评分进行Spearman相关分析和多元线性回归分析。

结果在115例烟雾病患者中，MTT评分（r=0.41，P<0.01）与DSA侧支代偿评分呈正相关。DSA侧支代偿评分（β=0.31，P=0.02）、性别（β=1.20，P=0.01）、临床分型（β=2.94，P<0.01）和卒中史（β=-1.19，P=0.02）是脑灌注改变的独立影响因素，女性患者的灌注优于男性患者（P=0.02），出血性患者的灌注优于缺血性患者（P=0.01），无卒中史的患者灌注优于有卒中史的患者（P=0.03）。

结论 DSA侧支代偿评分与MTT评分相关。DSA侧支代偿评分、性别、临床分型和卒中史是大脑半球灌注的独立影响因素。在评估旁路血管、新血管形成和术后预后时需要注意CT灌注。

文章导读： 本研究基于ASPECTS分区的烟雾病CT灌注与DSA侧支代偿评分的相关性，提出在评估旁路血管、新血管形成和术后预后时需要关注CT灌注。

关键词: 烟雾病; 计算机断层扫描灌注; 侧支代偿

Abstract:

Objective To explore the correlation between CT perfusion and DSA collateral compensation and the risk factors affecting cerebral hemisphere perfusion in patients with Moyamoya disease.

Methods A total of 115 adult Moyamoya disease patients with 230 cerebral hemispheres were enrolled in this study, and their DSA and CT perfusion data were collected. The ASPECTS was used to divide the brain regions and score four perfusion hemodynamic indicators including time to peak (TTP), mean transit time (MTT), cerebral blood flow (CBF), and cerebral blood volume (CBV), and to score the cerebrovascular collateral compensation displayed by DSA. Spearman correlation analysis and multiple linear regression analysis were performed on the four perfusion hemodynamic indicators and the DSA collateral compensation score.

Results In 115 patients with Moyamoya disease, MTT score (r=0.41, P<0.01) was positively correlated with the DSA collateral compensation score. The DSA collateral compensation score (β=0.31, P=0.02), gender (β=1.20, P=0.01), clinical type (β=2.94, P<0.01), and history of stroke (β=-1.19, P=0.02) were independent influencing factors for cerebral perfusion changes. Female patients had better perfusion than male patients (P=0.02), hemorrhagic patients had better perfusion than ischemic patients (P=0.01), and patients without a history of stroke had better perfusion than those with a history of stroke (P=0.03).

Conclusions The DSA collateral compensation score was correlated with the MTT score. Moreover, the DSA collateral compensation score, gender, clinical type, and history of stroke were independent influencing factors for cerebral hemisphere perfusion. CT perfusion should be considered when evaluating bypass vessels, neovascularization, and postoperative prognosis.

Key words: Moyamoya disease; Computed tomography perfusion; Collateral compensation

中图分类号:

杜海斌, 孙剑, 刘炜, 张东.

基于ASPECTS分区的烟雾病CT灌注与DSA侧支代偿的相关性研究 [J]. 中国卒中杂志, 2024, 19(7): 755-761.

DU Haibin, SUN Jian, LIU Wei, ZHANG Dong.

A Study on the Correlation between ASPECTS-Based CT Perfusion and DSA Collateral Compensation in Moyamoya Disease [J]. Chinese Journal of Stroke, 2024, 19(7): 755-761.

参考文献

[1] SUZUKI J，TAKAKU A. Cerebrovascular “Moyamoya”disease. Disease showing abnormal net-like vessels in base of brain[J]. Arch Neurol，1969，20（3）：288-299.

[2] ZHANG D，HUANG L R，HUANG Z，et al. Epidemiology of Moyamoya disease in China：a nationwide hospital-based study[J/OL]. Lancet Reg Health West Pac，2022，18：100331[2024-04-01]. https://doi.org/10.1016/j.lanwpc.2021.100331.

[3] HAN D H，NAM D H，OH C W. Moyamoya disease in adults：characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis [J/OL]. Clin Neurol Neurosurg，1997，99 Suppl 2：S151-S155[2024-04-01]. https://doi.org/10.1016/s0303-8467（97）00058-9.

[4] BABA T，HOUKIN K，KURODA S. Novel epidemiological features of Moyamoya disease[J]. J Neurol Neurosurg Psychiatry，2008，79（8）：900-904.

[5] HAN D H，KWON O K，BYUN B J，et al. A co-operative study：clinical characteristics of 334 Korean patients with Moyamoya disease treated at neurosurgical institutes（1976—1994）[J]. Acta Neurochir（Wien），2000，142（11）：1263-1274.

[6] Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis，Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of Moyamoya disease（spontaneous occlusion of the circle of Willis）[J]. Neurol Med Chir（Tokyo），2012，52（5）：245-266.

[7] SCOTT R M，SMITH E R. Moyamoya disease and Moyamoya syndrome[J]. N Engl J Med，2009，360（12）：1226-1237.

[8] LIU Z W，HAN C，WANG H，et al. Clinical characteristics and leptomeningeal collateral status in pediatric and adult patients with ischemic Moyamoya disease[J]. CNS Neurosci Ther，2020，26（1）：14-20.

[9] ZHAO Y H，LU J L，ZHANG Q，et al. Time course of neoangiogenesis after indirect bypass surgery for Moyamoya disease：comparison of short-term and long-term follow-up angiography[J]. Clin Neuroradiol，2020，30（1）：91-99.

[10] KANG K J，MA N，LI J X，et al. Cerebral hemodynamic changes after revascularization in patients with hemorrhagic Moyamoya disease[J/OL]. Front Neurol，2020，11：72[2024-04-01]. https://doi.org/10.3389/fneur.2020.00072.

[11] GUO X，YUAN X X，GAO L Y，et al. Encephaloduroarteriosynangiosis（EDAS）treatment of Moyamoya syndrome：evaluation by computed tomography perfusion imaging[J]. Eur Radiol，2021，31（11）：8364-8373.

[12] FUJIMURA M，TOMINAGA T，KURODA S，et al. 2021 Japanese guidelines for the management of Moyamoya disease：guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society[J]. Neurol Med Chir（Tokyo），2022，62（4）：165-170.

[13] LIU Z W，HAN C，ZHAO F，et al. Collateral circulation in Moyamoya disease：a new grading system[J]. Stroke，2019，50（10）：2708-2715.

[14] HUNGERFORD J P，HYER M，TURK A S，et al. Impact of ASPECT scores and infarct distribution on outcomes among patients undergoing thrombectomy for acute ischemic stroke with the ADAPT technique[J]. J Neurointerv Surg，2017，9（9）：823-829.

[15] KURODA S，HOUKIN K. Moyamoya disease：current concepts and future perspectives[J]. Lancet Neurol，2008，7（11）：1056-1066.

[16] TOGAO O，MIHARA F，YOSHIURA T，et al. Cerebral hemodynamics in Moyamoya disease：correlation between perfusion-weighted MR imaging and cerebral angiography[J]. AJNR Am J Neuroradiol，2006，27（2）：391-397.

[17] SHI Z Y，MA G F，ZHANG D. Haemodynamic analysis of adult patients with Moyamoya disease：CT perfusion and DSA gradings[J]. Stroke Vasc Neurol，2021，6（1）：41-47.

[18] YIN H，LIU X J，ZHANG D，et al. A novel staging system to evaluate cerebral hypoperfusion in patients with Moyamoya disease[J]. Stroke，2018，49（12）：2837-2843.

[19] CHEN Y Q，XU W J，GUO X，et al. CT perfusion assessment of Moyamoya syndrome before and after direct revascularization（superficial temporal artery to middle cerebral artery bypass）[J]. Eur Radiol，2016，26（1）：254-261.

[20] ZHANG J，WANG J H，GENG D Y，et al. Whole-brain CT perfusion and CT angiography assessment of Moyamoya disease before and after surgical revascularization：preliminary study with 256-slice CT[J/OL]. PLoS One，2013，8（2）：e57595[2024-04-01]. https://doi.org/10.1371/journal.pone.0057595.

[21] CHEN Y，MA L，LU J L，et al. Postoperative hemorrhage during the acute phase after direct or combined revascularization for Moyamoya disease：risk factors，prognosis，and literature review[J]. J Neurosurg，2019，133（5）：1450-1459.

[22] SHI Z Y，WEN Y J，HUANG Z，et al. Different ASPECTS of cognitive function in adult patients with Moyamoya disease and its clinical subtypes[J]. Stroke Vasc Neurol，2020，5（1）：86-96.

[23] HARA Y，WATERS E M，MCEWEN B S，et al. Estrogen effects on cognitive and synaptic health over the lifecourse[J]. Physiol Rev，2015，95（3）：785-807.

[24] STROTHER C M，BENDER F，DEUERLING-ZHENG Y，et al. Parametric color coding of digital subtraction angiography[J]. AJNR Am J Neuroradiol，2010，31（5）：919-924.

[25] CHEN Y，MA L，YANG S，et al. Quantitative angiographic hemodynamic evaluation after revascularization surgery for Moyamoya disease[J]. Transl Stroke Res，2020，11（5）：871-881.

基于ASPECTS分区的烟雾病CT灌注与DSA侧支代偿的相关性研究

A Study on the Correlation between ASPECTS-Based CT Perfusion and DSA Collateral Compensation in Moyamoya Disease

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	韩聪. 烟雾病基础和临床研究面临的问题与挑战[J]. 中国卒中杂志, 2024, 19(7): 735-739.
[2]	陈方舟, 龙廷翰, 陈俊达, 温运宇, 陈思源, 张国忠, 李明洲, 张世超, 康慧斌, 冯文峰, 漆松涛, 王刚. 受体动脉不同临时阻断策略在烟雾病颞浅动脉-大脑中动脉搭桥术中的应用比较 [J]. 中国卒中杂志, 2024, 19(7): 762-768.
[3]	姚阳, 傅锴锴, 朱俊蓉, 赵明, 陈蕾, 韩易, 李强, 张萍 . 成人烟雾病患者认知功能的长期研究 [J]. 中国卒中杂志, 2024, 19(7): 769-776.
[4]	张厚地, 汪敏杰, 张茜, 沈栩轩, 符荷琯, 韩聪. 基于烟雾病慢性脑缺血患者主观睡眠质量的影响因素分析 [J]. 中国卒中杂志, 2024, 19(7): 777-784.
[5]	刘洋, 杨俊华, 吴俊, 王硕. 血管样本生物信息学分析鉴定烟雾病相关的潜在关键基因[J]. 中国卒中杂志, 2024, 19(4): 431-439.
[6]	任晓佳, 刘关杰, 郝汶强. 金纳多治疗烟雾病所致缺血性卒中个案报道[J]. 中国卒中杂志, 2023, 18(9): 1060-1064.
[7]	罗婉贤, 何逸清, 李颖嘉. 烟雾病颅内外血管参数评估研究进展 [J]. 中国卒中杂志, 2023, 18(04): 490-494.
[8]	刘成龙, 张谦, 赵继宗. 甲状腺功能亢进合并烟雾病发病机制的研究进展[J]. 中国卒中杂志, 2023, 18(03): 353-358.
[9]	桂金敏, 薛锐, 李娜, 刘青林, 赵东红. 个体化血压及液体管理对烟雾病脑血管重建术后过度灌注综合征的影响 [J]. 中国卒中杂志, 2022, 17(12): 1350-1354.
[10]	韩广淞, 倪俊. 烟雾病临床分型研究进展[J]. 中国卒中杂志, 2022, 17(10): 1120-1126.
[11]	符荷琯, 沈栩轩, 徐佳丽, 张厚地, 李斌, 邹正兴, 冯捷, 段炼, 韩聪. 青年烟雾病患者的卒中类型及危险因素分析 [J]. 中国卒中杂志, 2022, 17(09): 937-943.
[12]	康帅, 韩鹤泽, 鲁峻麟, 陈晓霖, 陈玉, 叶迅, 王嵘, 赵元立. 烟雾病血运重建术后非感染性发热的发病率与危险因素分析[J]. 中国卒中杂志, 2022, 17(07): 742-747.
[13]	暴向阳, 段炼. 烟雾病方向研究生的培养和带教体会[J]. 中国卒中杂志, 2022, 17(04): 426-428.
[14]	张圣楠, 张盼盼, 庞宇菲, 张斌, 马娜, 刘远洪. 脑皮质静脉显影评分评估皮质静脉充盈的优化与探讨[J]. 中国卒中杂志, 2022, 17(02): 128-133.
[15]	孙大鹏, 霍晓川, 马高亭, 佟旭, 张雪蕾, 缪中荣. 自动化头颅计算机断层扫描灌注成像在脑急性大血管闭塞血管内治疗中的应用研究进展[J]. 中国卒中杂志, 2021, 16(11): 1092-1098.